Detection of postoperative residual cholesteatoma with non-echo-planar diffusion-weighted magnetic resonance imaging

Bert De Foer1, Jean-Philippe Vercruysse, Anja Bernaerts

  • 1Department of Radiology, Augustinus Hospital, Wilrijk, Belgium. bert.defoer@GZA.be

Abstract

Insights

Non-echo-planar imaging (non-EPI)-based diffusion-weighted (DW) magnetic resonance imaging (MRI) effectively detects residual cholesteatoma after mastoidectomy. This imaging technique aids in selecting patients for second-look surgery, preventing unnecessary procedures.

Area of Science:

  • Otolaryngology
  • Radiology
  • Medical Imaging

Background:

  • Cholesteatoma recurrence after surgery requires accurate detection.
  • Second-look surgery is often performed to confirm residual cholesteatoma.
  • Non-invasive imaging can potentially obviate the need for second-look surgery.

Purpose of the Study:

  • To evaluate the efficacy of non-echo-planar imaging (non-EPI)-based diffusion-weighted (DW) magnetic resonance imaging (MRI) in detecting residual cholesteatoma.
  • To assess the role of non-EPI DW MRI in guiding decisions for second-look surgery after canal wall-up mastoidectomy.

Main Methods:

  • Prospective, blinded study involving 32 patients.
  • Patients underwent MRI, including late postgadolinium T1-weighted and non-EPI DW sequences, 10-18 months post-surgery.
  • Imaging findings were correlated with surgical or clinical follow-up outcomes.

Main Results:

  • Non-EPI DW MRI detected 9 out of 10 residual cholesteatomas, with sizes ranging from 2 to 6 mm.
  • The imaging demonstrated high sensitivity (90%) and specificity (100%) for residual cholesteatoma detection.
  • One small cholesteatoma was missed due to motion artifacts in a pediatric patient.

Conclusions:

  • Non-EPI DW MRI is highly effective in detecting small residual cholesteatomas, except in cases with motion artifacts.
  • This advanced MRI technique can accurately identify patients who would benefit from second-look surgery.
  • Non-EPI DW MRI has the potential to reduce unnecessary second-look surgeries.